Coronary Heart Disease/Myocardial Infarction: Intravenous Fluosol in the Treatment of Acute Myocardial Infarction: Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial - TAMI-9


The TAMI-9 trial was a prospective, multicenter, randomized, open-labeled, placebo-controlled trial, designed to determine the safety and potential efficacy of an intravenous perfluorochemical emulsion (Fluosol) as an adjunct reperfusion therapy aimed at preventing reperfusion injury for patients with acute myocardial infarction.